The artificial intelligence (AI) market has created some monster growth stocks already, but companies involved in enabling this technological revolution are still seeing growing opportunities. Here ...
LONDON] British Prime Minister Keir Starmer will host a major international investment summit on Monday (Oct 14), with his ...
When UK Prime Minister Keir Starmer welcomes business leaders to a major investment summit in London on Monday, his message ...
In a report released on October 10, David Evans from Kepler Capital maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), ...
We recently published an article titled Jim Cramer on Super Micro Computer and Other Stocks. In this article, we are going to ...
Biohaven has surged driven by promising data from its troriluzole trials for spinocerebellar ataxia and ongoing OCD studies.
GSK settles 93% of Zantac lawsuits with a $2.2 billion payout, easing investor concerns. However, doubts over its future ...
GSK paid $22.4 million on Sept. 27 for 2.8 million more shares of Wave Life Sciences for $8 each. GSK now owns 16.8 million ...
With reports swirling about potential interest in Sanofi’s consumer health business, the French pharma has confirmed that a ...
John Maraganore, the former CEO of Alnylam Pharmaceuticals, launched City Therapeutics, a new startup with $135 million from ...
When Investors Make Decisions in Gsk Plc American Depositary Shares (each Representing Two) GSK Opportunities Surface ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback